Utility of myxedema score as a predictor of mortality in myxedema coma.

Chaudhary, S; Das, L; Sharma, N; Sachdeva, N; Bhansali, A; Dutta, P

Chaudhary, S; Das, L; Sharma, N; Sachdeva, N; Bhansali, A; Dutta, P.

Afiliação

Chaudhary S; Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Nehru Extension Block, 1012, Chandigarh, 160012, India.
Das L; Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Nehru Extension Block, 1012, Chandigarh, 160012, India.
Sharma N; Department of Internal Medicine, PGIMER, Chandigarh, India.
Sachdeva N; Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Nehru Extension Block, 1012, Chandigarh, 160012, India.
Bhansali A; Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Nehru Extension Block, 1012, Chandigarh, 160012, India.
Dutta P; Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Nehru Extension Block, 1012, Chandigarh, 160012, India. drpinakidutta12@gmail.com.

J Endocrinol Invest ; 46(1): 59-65, 2023 Jan.

Article em En | MEDLINE | ID: mdl-35945394

Assuntos

Hipotireoidismo; Mixedema; Sepse; Humanos; Feminino; Masculino; Mixedema/diagnóstico; Mixedema/complicações; Coma/complicações; Coma/diagnóstico; Hipotireoidismo/complicações; Tiroxina; Mortalidade Hospitalar; Sepse/complicações; Estudos Retrospectivos

Palavras-chave

IV levothyroxine; Myxedema coma; Myxedema score; Predictors of mortality; qSOFA score

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sepse / Hipotireoidismo / Mixedema Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Endocrinol Invest Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google